Cure My Disease

Don't miss your cure!

 Log in / Sign up

Immunotherapy combo shows promise in advanced lung cancer trial

NCT ID NCT02572843

Completed Disease control Sponsor: Swiss Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether adding an immunotherapy drug (MEDI4736) to standard chemotherapy before surgery helps people with stage IIIA non-small cell lung cancer. 68 participants received the combination treatment. The goal was to see if this approach improves how long people live without their cancer coming back. Results suggest the combination is effective and feasible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NSCLC (NON-SMALL CELL LUNG CANCER)

Contacts and locations

Locations

  • CCAC Lausanne

    Lausanne, 1004, Switzerland

  • Centre hospitalier universitaire vaudois CHUV

    Lausanne, CH-1011, Switzerland

  • Hopital Cantonal Universitaire de Geneve

    Geneva, CH-1211, Switzerland

  • Hopital Fribourgeois HFR

    Fribourg, 1708, Switzerland

  • IOSI Ospedale Regionale di Bellinzona e Valli

    Bellinzona, 6500, Switzerland

  • Inselspital Bern

    Bern, CH-3010, Switzerland

  • Kantonsspital Aarau

    Aarau, CH-5001, Switzerland

  • Kantonsspital Baden

    Baden, 5404, Switzerland

  • Kantonsspital Graubuenden

    Chur, CH-7000, Switzerland

  • Kantonsspital St. Gallen

    Sankt Gallen, 9007, Switzerland

  • Kantonsspital Winterthur

    Winterthur, CH-8401, Switzerland

  • Klinik Hirslanden Onkozentrum Zürich

    Zurich, CH-8032, Switzerland

  • Luzerner Kantonsspital

    Lucerne, CH-6000, Switzerland

  • Regionalspital

    Thun, 3600, Switzerland

  • Spital Thurgau AG

    Frauenfeld, CH-8500, Switzerland

  • St. Claraspital Basel

    Basel, 4016, Switzerland

  • Stadtspital Triemli

    Zurich, Canton of Zurich, 8063, Switzerland

  • UniversitaetsSpital Zuerich

    Zurich, CH-8091, Switzerland

  • Universitaetsspital Basel

    Basel, 4031, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.